783 related articles for article (PubMed ID: 19132190)
1. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
2. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
3. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
4. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
5. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.
de Visser MC; Poort SR; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2001 Jun; 85(6):1011-7. PubMed ID: 11434677
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
van Minkelen R; de Visser MC; Houwing-Duistermaat JJ; Vos HL; Bertina RM; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1486-91. PubMed ID: 17413037
[TBL] [Abstract][Full Text] [Related]
7. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
8. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M
Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318
[TBL] [Abstract][Full Text] [Related]
11. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
Aléssio AM; Höehr NF; Siqueira LH; Ozelo MC; de Pádua Mansur A; Annichino-Bizzacchi JM
Thromb Res; 2007; 120(5):639-45. PubMed ID: 17184825
[TBL] [Abstract][Full Text] [Related]
12. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
[TBL] [Abstract][Full Text] [Related]
13. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
[TBL] [Abstract][Full Text] [Related]
14. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.
Pomp ER; Rosendaal FR; Doggen CJ
Am J Hematol; 2008 Feb; 83(2):97-102. PubMed ID: 17726684
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
16. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
[TBL] [Abstract][Full Text] [Related]
17. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
[TBL] [Abstract][Full Text] [Related]
18. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
Nossent AY; Eikenboom JC; Vos HL; Bakker E; Tanis BC; Doggen CJ; Bertina RM; Rosendaal FR
Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
20. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]